vs
bioAffinity Technologies, Inc.（BIAF）与REZOLVE AI PLC（RZLV）财务数据对比。点击上方公司名可切换其他公司
bioAffinity Technologies, Inc.的季度营收约是REZOLVE AI PLC的1.3倍（$1.6M vs $1.2M），bioAffinity Technologies, Inc.净利率更高（-197.0% vs -1078.8%，领先881.8%）
bioAffinity Technologies是一家处于临床阶段的生物技术企业，专注于研发可用于癌症、呼吸系统疾病早期检测的非侵入性体外诊断产品，面向全球医疗市场，致力于提供高准确率的便捷诊断方案，改善患者诊疗体验与预后效果。
REZOLVE AI PLC是总部位于英国的科技企业，开发人工智能驱动的移动互动与即时交易平台，支持用户直接从音频、视频、印刷内容中完成购买，服务欧洲、北美及部分亚太市场的零售、消费品与媒体客户。
BIAF vs RZLV — 直观对比
营收规模更大
BIAF
是对方的1.3倍
$1.2M
净利率更高
BIAF
高出881.8%
-1078.8%
损益表 — Q4 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6M | $1.2M |
| 净利润 | $-3.1M | $-13.0M |
| 毛利率 | — | — |
| 营业利润率 | -196.9% | -808.4% |
| 净利率 | -197.0% | -1078.8% |
| 营收同比 | -27.8% | — |
| 净利润同比 | -5.7% | — |
| 每股收益（稀释后） | $-3.59 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIAFRZLV
| Q4 25 | $1.6M | — | ||
| Q3 25 | $1.4M | — | ||
| Q2 25 | $1.3M | $1.2M | ||
| Q1 25 | $1.9M | — | ||
| Q4 24 | $2.2M | — | ||
| Q3 24 | $2.4M | — | ||
| Q2 24 | $2.4M | — | ||
| Q1 24 | $2.4M | — |
净利润BIAFRZLV
| Q4 25 | $-3.1M | — | ||
| Q3 25 | $-5.1M | — | ||
| Q2 25 | $-4.1M | $-13.0M | ||
| Q1 25 | $-2.7M | — | ||
| Q4 24 | $-3.0M | — | ||
| Q3 24 | $-2.0M | — | ||
| Q2 24 | $-2.1M | — | ||
| Q1 24 | $-2.0M | — |
营业利润率BIAFRZLV
| Q4 25 | -196.9% | — | ||
| Q3 25 | -158.6% | — | ||
| Q2 25 | -198.2% | -808.4% | ||
| Q1 25 | -141.7% | — | ||
| Q4 24 | -133.5% | — | ||
| Q3 24 | -84.0% | — | ||
| Q2 24 | -87.1% | — | ||
| Q1 24 | -80.8% | — |
净利率BIAFRZLV
| Q4 25 | -197.0% | — | ||
| Q3 25 | -349.3% | — | ||
| Q2 25 | -319.9% | -1078.8% | ||
| Q1 25 | -143.5% | — | ||
| Q4 24 | -134.4% | — | ||
| Q3 24 | -85.1% | — | ||
| Q2 24 | -88.0% | — | ||
| Q1 24 | -81.5% | — |
每股收益（稀释后）BIAFRZLV
| Q4 25 | $-3.59 | — | ||
| Q3 25 | $-4.74 | — | ||
| Q2 25 | $-0.17 | — | ||
| Q1 25 | $-0.16 | — | ||
| Q4 24 | $-17.27 | — | ||
| Q3 24 | $-4.84 | — | ||
| Q2 24 | $-0.19 | — | ||
| Q1 24 | $-0.20 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.3M | $-14.3M |
| 总资产 | $11.0M | $80.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BIAFRZLV
| Q4 25 | $6.4M | — | ||
| Q3 25 | $7.7M | — | ||
| Q2 25 | $802.8K | — | ||
| Q1 25 | $444.7K | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $756.6K | — | ||
| Q2 24 | $801.3K | — | ||
| Q1 24 | $2.5M | — |
股东权益BIAFRZLV
| Q4 25 | $7.3M | — | ||
| Q3 25 | $8.9M | — | ||
| Q2 25 | $-2.1M | $-14.3M | ||
| Q1 25 | $1.4M | — | ||
| Q4 24 | $2.6M | — | ||
| Q3 24 | $3.1M | — | ||
| Q2 24 | $3.4M | — | ||
| Q1 24 | $5.3M | — |
总资产BIAFRZLV
| Q4 25 | $11.0M | — | ||
| Q3 25 | $11.5M | — | ||
| Q2 25 | $4.8M | $80.1M | ||
| Q1 25 | $5.5M | — | ||
| Q4 24 | $6.5M | — | ||
| Q3 24 | $6.6M | — | ||
| Q2 24 | $6.7M | — | ||
| Q1 24 | $8.0M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.6M | $-4.9M |
| 自由现金流经营现金流 - 资本支出 | $-2.6M | — |
| 自由现金流率自由现金流/营收 | -160.7% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-9.4M | — |
8季度趋势，按日历期对齐
经营现金流BIAFRZLV
| Q4 25 | $-2.6M | — | ||
| Q3 25 | $-2.5M | — | ||
| Q2 25 | $-2.6M | $-4.9M | ||
| Q1 25 | $-1.6M | — | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | $-1.7M | — | ||
| Q2 24 | $-1.5M | — | ||
| Q1 24 | $-2.3M | — |
自由现金流BIAFRZLV
| Q4 25 | $-2.6M | — | ||
| Q3 25 | $-2.5M | — | ||
| Q2 25 | $-2.7M | — | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | $-1.7M | — | ||
| Q2 24 | $-1.6M | — | ||
| Q1 24 | $-2.4M | — |
自由现金流率BIAFRZLV
| Q4 25 | -160.7% | — | ||
| Q3 25 | -171.8% | — | ||
| Q2 25 | -209.6% | — | ||
| Q1 25 | -91.3% | — | ||
| Q4 24 | -76.0% | — | ||
| Q3 24 | -73.1% | — | ||
| Q2 24 | -65.1% | — | ||
| Q1 24 | -99.2% | — |
资本支出强度BIAFRZLV
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 2.7% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 1.7% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
